Gilead Sciences
GILD
GILD
1,706 hedge funds and large institutions have $75.9B invested in Gilead Sciences in 2024 Q1 according to their latest regulatory filings, with 138 funds opening new positions, 633 increasing their positions, 726 reducing their positions, and 169 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,706
Holders Change
-55
Holders Change %
-3.12%
% of All Funds
24.73%
Holding in Top 10
14
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-39.13%
% of All Funds
0.2%
New
138
Increased
633
Reduced
726
Closed
169
Calls
$728M
Puts
$684M
Net Calls
+$43.8M
Net Calls Change
+$127M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
$390M |
| 2 |
Two Sigma Advisers
New York
|
$372M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
$257M |
| 4 |
Two Sigma Investments
New York
|
$234M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$8.4B |
Top Sellers
| 1 |
Morgan Stanley
New York
|
$1.32B |
| 2 |
Parnassus Investments
San Francisco,
California
|
$105M |
| 3 |
Neuberger Berman Group
New York
|
$70.6M |
| 4 |
Goldman Sachs
New York
|
$380M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$522M |
